Metabolic Acidosis In Chronic Kidney Disease (CKD)
Expert nephrologist, Dr. Samuel A Kantor, will discuss metabolic acidosis in CKD.
- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Attend live and virtual events that provide a platform for education and collaborative discussion about the management of kidney disease and strategies to improve kidney health.
Any NephU member can request a presentation for their region or organization at no charge.
Featured Events
Events
Increasing Awareness Of Autosomal Dominant Polycystic Kidney Disease (ADPKD) In Underrepresented & Underserved Communities
This presentation focuses on the impact of kidney disease and autosomal dominant polycystic kidney disease (ADPKD) in Black and Hispanic/Latino communities and the effects of social determinants of health on patients living with kidney. Diagnosing and managing the care of patients living with ADPKD will also be discussed.
Factors Influencing Drug Dialyzability
In this webinar, the speakers will review medication information resources and present an approach to administration of medications when dialyzability data are limited in the hemodialysis and peritoneal dialysis populations.
Role Of Obesity & Diet In Polycystic Kidney Disease (PKD) Progression
Please join us and our leading expert, Kristen Nowak, PhD, MPH, as she showcases her laboratory findings about the complex relationship between diet, obesity and the role that they play in disease progression.
Role Of Obesity & Diet In Polycystic Kidney Disease (PKD) Progression
Please join us and our leading expert, Kristen Nowak, PhD, MPH, as she showcases her laboratory findings about the complex relationship between diet, obesity and the role that they play in disease progression.
Assessing Pain & Its Impact In Autosomal Dominant Polycystic Kidney Disease (ADPKD): The ADPKD Pain & Discomfort Scale (ADPKD – PDS)
This webinar will discuss the impact of pain in patients with ADPKD and the applications of a new tool in standardizing assessment of pain.
Screening & Differential Diagnosis For Autosomal Dominant Polycystic Kidney Disease (ADPKD)
This webinar will discuss a diagnostic work up for ADPKD and walk through a diagnostic algorithm including a differential diagnosis for cystic kidney disease.
Screening & Differential Diagnosis For Autosomal Dominant Polycystic Kidney Disease (ADPKD)
This webinar will discuss a diagnostic work up for ADPKD and walk through a diagnostic algorithm including a differential diagnosis for cystic kidney disease.
Kidney Healthy Cooking Series With Celebrity Chef JJ – Episode 4: Pumpkin Pancakes With Berry Compote
This webinar highlights Chef JJ's kidney healthy pumpkin pancake and berry compote recipe along with a discussion on the deeper dietary details from Misty Nason.
Genetic Testing in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
In this presentation, the complexities of genetic testing in ADPKD, recommendations on when genetic testing is appropriate and indicated, and the various types of molecular genetic tests available will be discussed.
Hypertension In Autosomal Dominant Polycystic Kidney Disease (ADPKD), Chronic Kidney Disease (CKD), & The General Population
Dr. Workeneh, a double Board-certified nephrologist and internist, and professor will discuss the pathophysiology and management of HTN in patients with ADPKD, CKD, and the GP.
How Radiologic Technologists Impact the Diagnosis & Prognosis of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Autosomal Dominant Polycystic Kidney Disease (ADPKD), an inherited progressive kidney disease, is the fourth leading cause of kidney failure in the US. ADPKD has a spectrum of clinical and imaging features that have direct prognostic implications1. Total kidney volume (TKV), adjusted for height and age, has been shown to be the best predictor of kidney function decline; this forms the basis for the Mayo Clinic Imaging Classification (MCIC) of the severity grade of ADPKD1. Radiology’s central role in ADPKD is to aid in the imaging-based diagnosis, prognostication, and monitoring for disease progression.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
